These findings imply that NK357 and NK391can additively alleviate gingival pathogen-induced periodontitis, colitis, neuroinflammation, and CI by suppressing NF-κB and RANK/RANKL signaling pathways and modulating gut microbiota. This evidence concerns the gene NFKB1 and colitis.